In these experiments, CDDP administration slightly increased ABCG2 expression in CD45(−) and CD34(−) (immune-cell and endothelial markers described in ref. 42) cancer cell sub-populations (Figure 6G, 6H). This evidence concerns the gene PTPRC and cancer.